LISATA THERAPEUTICS, INC. Long-Term Debt, Maturity, Year Three
LISATA THERAPEUTICS, INC. (LSTA) had Long-Term Debt, Maturity, Year Three of $100.00 thousand as of 2016-06-30, per its 10-Q filed 2016-11-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2016-11-07
- 2016-06-30: Long-Term Debt, Maturity, Year Three $100.00K; Long-Term Debt, Maturity, Year Three as first filed $400.00K.
- 2016-03-31: Long-Term Debt, Maturity, Year Three $600.00K.
- 2015-09-30: Long-Term Debt, Maturity, Year Three $5.30M.
- 2015-06-30: Long-Term Debt, Maturity, Year Three $5.30M.
| Period end | Long-Term Debt, Maturity, Year Three | Long-Term Debt, Maturity, Year Three as first filed |
|---|---|---|
| 2016-06-30 | $100.00K 10-Q · filed 2016-11-07 | $400.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $600.00K 10-Q · filed 2016-05-05 | |
| 2015-09-30 | $5.30M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $5.30M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.70M 10-Q · filed 2015-05-06 | |
| 2014-09-30 | $5.70M 10-Q · filed 2014-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |